ACTRN12612000143820尚未招募未知
The Effect of Olopatadine Hydrochloride on total ocular symptoms score in Non-allergic conjunctivitis/rhinitis individuals.
A/Prof Peter Smith0 个研究点目标入组 20 人开始时间: 2012年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •No allergic conjunctivitis
- •Over 18 years
- •Not pregnant
- •CONFIRMED PARTICIPANTS CANT HAVE AR/AC
排除标准
- •allergic conjunctivitis/rhinitis
研究者
相似试验
进行中（未招募）
1 期
Study of Olopatadine Hydrochloride Ophthalmic Solution in the Treatment of Allergic Conjunctivitis in Chinese SubjectsAllergic conjunctivitisMedDRA version: 20.0Level: LLTClassification code 10001709Term: Allergic conjunctivitisSystem Organ Class: 100000014962EUCTR2016-004317-27-Outside-EU/EEAAlcon China Ophthalmic250
已完成
不适用
Impact of olopatadine hydrochloride(allelock(R)) against scratching behavior of atopic dermatitis patients at night.Atopic dermatitisJPRN-UMIN000010519Mie University, Graduate School of Medicine25
已完成
不适用
Clinical evaluation of 0.1% olopatadine hydrochloride ophthalmic solution in pediatric patientsallergic conjunctivitsJPRN-UMIN000005931Alcon Japan Ltd.40
招募中
2 期
The Effect of Alendronate in the Treatment of Osteopenia due to Acute LeukemiaAcute myeloblastic leukemiaCondition 1: Acute Lymphoblastic Leukemia. Condition 2: Acute Myeloblastic Leukemia.Acute lymphoblastic leukemia [ALL]C91.0C92.0IRCT20200916048733N1Tabriz University of Medical Sciences30
已完成
3 期
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese SubjectsAllergic ConjunctivitisNCT02322216Alcon Research383